Other Species / Isoforms
  CBCP1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S12-p
TSCCVSSsPKLRRNA
1 1
CBCP1 (human) TSCCVSSsPKLRRNA S12-p
CBCP1 iso3 (human) gap -
CBCP1 (mouse) TSCCVSSSPKLRRNA S12
CBCP1 (rat) TSCCVSSSPKLRRNA S12
S21-p
KLRRNAHsRLEsyRP
0 38
CBCP1 (human) KLRRNAHsRLEsyRP S21-p
CBCP1 iso3 (human) gap -
CBCP1 (mouse) KLRRNAHsRLEsyRP S21-p
CBCP1 (rat) KLRRNAHSRLEsYRP S21
S25-p
NAHsRLEsyRPDtDL
Upstream
0 47
Treatment
  • selumetinib
  • vemurafenib
CBCP1 (human) NAHsRLEsyRPDtDL S25-p
CBCP1 iso3 (human) gap -
CBCP1 (mouse) NAHsRLEsyRPDtDL S25-p
CBCP1 (rat) NAHSRLEsYRPDTDL S25-p
Y26-p
AHsRLEsyRPDtDLs
0 10
CBCP1 (human) AHsRLEsyRPDtDLs Y26-p
CBCP1 iso3 (human) gap -
CBCP1 (mouse) AHsRLEsyRPDtDLs Y26-p
CBCP1 (rat) AHSRLEsYRPDTDLS Y26
T30-p
LEsyRPDtDLsREDt
0 3
CBCP1 (human) LEsyRPDtDLsREDt T30-p
CBCP1 iso3 (human) gap -
CBCP1 (mouse) LEsyRPDtDLsREDt T30-p
CBCP1 (rat) LEsYRPDTDLSREDt T30
S33-p
yRPDtDLsREDtGCN
0 6
CBCP1 (human) yRPDtDLsREDtGCN S33-p
CBCP1 iso3 (human) gap -
CBCP1 (mouse) yRPDtDLsREDtGCN S33-p
CBCP1 (rat) YRPDTDLSREDtGCN S33
T37-p
tDLsREDtGCNLQHI
0 31
CBCP1 (human) tDLsREDtGCNLQHI T37-p
CBCP1 iso3 (human) gap -
CBCP1 (mouse) tDLsREDtGCNLQHI T37-p
CBCP1 (rat) TDLSREDtGCNLQHI T37-p
S45
GCNLQHISDRENIDD
0 1
CBCP1 (human) GCNLQHISDRENIDD S45
CBCP1 iso3 (human) gap -
CBCP1 (mouse) GCNLQHIsDRENIDD S45-p
CBCP1 (rat) GCNLQHISDRENIDD S45
S66-p
PSDHPRAstIFLsks
Upstream
0 17
Treatment
  • anti-CD3
CBCP1 (human) PSDHPRAstIFLsks S66-p
CBCP1 iso3 (human) PSDHPRASTIFLSKS S12
CBCP1 (mouse) PSDHPRAstIFLsks S66-p
CBCP1 (rat) PSDHPRAsTIFLSKS S66-p
T67-p
SDHPRAstIFLsksQ
Upstream
1 4
Kinase, in vitro:
  • CDK14 (human)
CBCP1 (human) SDHPRAstIFLsksQ T67-p
CBCP1 iso3 (human) SDHPRASTIFLSKSQ T13
CBCP1 (mouse) SDHPRAstIFLsksQ T67-p
CBCP1 (rat) SDHPRAsTIFLSKSQ T67
S71-p
RAstIFLsksQtDVR
Upstream
Downstream
1 6
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Kinase, in vitro:
  • CDK14 (human)
Putative in vivo kinases:
  • CDK14 (human)
Treatment
  • siRNA
CBCP1 (human) RAstIFLsksQtDVR S71-p
CBCP1 iso3 (human) RASTIFLSKSQTDVR S17
CBCP1 (mouse) RAstIFLsksQtDVR S71-p
CBCP1 (rat) RAsTIFLSKSQTDVR S71
K72-ub
AstIFLsksQtDVRE
0 5
CBCP1 (human) AstIFLsksQtDVRE K72-ub
CBCP1 iso3 (human) ASTIFLSKSQTDVRE K18
CBCP1 (mouse) AstIFLsksQtDVRE K72-ub
CBCP1 (rat) AsTIFLSKSQTDVRE K72
S73-p
stIFLsksQtDVREK
Upstream
Downstream
1 66
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Kinase, in vitro:
  • CDK14 (human)
Putative in vivo kinases:
  • CDK14 (human)
Treatment
  • ischemia
  • siRNA
CBCP1 (human) stIFLsksQtDVREK S73-p
CBCP1 iso3 (human) STIFLSKSQTDVREK S19
CBCP1 (mouse) stIFLsksQtDVREK S73-p
CBCP1 (rat) sTIFLSKSQTDVREK S73
T75-p
IFLsksQtDVREKRK
0 19
CBCP1 (human) IFLsksQtDVREKRK T75-p
CBCP1 iso3 (human) IFLSKSQTDVREKRK T21
CBCP1 (mouse) IFLsksQtDVREKRK T75-p
CBCP1 (rat) IFLSKSQTDVREKRK T75
S83-p
DVREKRKsLFINHHP
Upstream
1 38
Kinase, in vitro:
  • CDK14 (human)
Treatment
  • angiotensin_2
  • LRRK2-IN-1
  • Y27632
CBCP1 (human) DVREKRKsLFINHHP S83-p
CBCP1 iso3 (human) DVREKRKSLFINHHP S29
CBCP1 (mouse) DVREKRKsLFINHHP S83-p
CBCP1 (rat) DVREKRKSLFINHHP S83
Y98-p
PGQIARKyssCstIF
0 1
CBCP1 (human) PGQIARKyssCstIF Y98-p
CBCP1 iso3 (human) PGQIARKYSSCSTIF Y44
CBCP1 (mouse) PGQTSRKYSsCstIF Y98
CBCP1 (rat) PGQTSRKYSSCSTIF Y98
S99-p
GQIARKyssCstIFL
0 1
CBCP1 (human) GQIARKyssCstIFL S99-p
CBCP1 iso3 (human) GQIARKYSSCSTIFL S45
CBCP1 (mouse) GQTSRKYSsCstIFL S99
CBCP1 (rat) GQTSRKYSSCSTIFL S99
S100-p
QIARKyssCstIFLD
1 7
CBCP1 (human) QIARKyssCstIFLD S100-p
CBCP1 iso3 (human) QIARKYSSCSTIFLD S46
CBCP1 (mouse) QTSRKYSsCstIFLD S100-p
CBCP1 (rat) QTSRKYSSCSTIFLD S100
S102-p
ARKyssCstIFLDDS
0 3
CBCP1 (human) ARKyssCstIFLDDS S102-p
CBCP1 iso3 (human) ARKYSSCSTIFLDDS S48
CBCP1 (mouse) SRKYSsCstIFLDDS S102-p
CBCP1 (rat) SRKYSSCSTIFLDDS S102
T103-p
RKyssCstIFLDDST
0 2
CBCP1 (human) RKyssCstIFLDDST T103-p
CBCP1 iso3 (human) RKYSSCSTIFLDDST T49
CBCP1 (mouse) RKYSsCstIFLDDST T103-p
CBCP1 (rat) RKYSSCSTIFLDDST T103
S153-p
DENLHPLsKSEVPPD
0 1
CBCP1 (human) DENLHPLsKSEVPPD S153-p
CBCP1 iso3 (human) DENLHPLSKSEVPPD S99
CBCP1 (mouse) DENLHPLSKSEVPPD S153
CBCP1 (rat) DENLHPLSKSEVPPD S153
S280-p
KYYFDLRsLAEANNL
0 5
CBCP1 (human) KYYFDLRsLAEANNL S280-p
CBCP1 iso3 (human) KYYFDLRSLAEANNL S226
CBCP1 (mouse) KYYFDLRsLAEANNL S280-p
CBCP1 (rat) KYYFDLRSLAEANSL S280
S288-p
LAEANNLsFPLEPLs
Upstream
1 2
Kinase, in vitro:
  • CDK14 (human)
CBCP1 (human) LAEANNLsFPLEPLs S288-p
CBCP1 iso3 (human) LAEANNLSFPLEPLS S234
CBCP1 (mouse) LAEANNLsFPLEPLs S288-p
CBCP1 (rat) LAEANSLSFPLEPLS S288
S295-p
sFPLEPLsRERAHkL
Upstream
1 2
Kinase, in vitro:
  • CDK14 (human)
CBCP1 (human) sFPLEPLsRERAHkL S295-p
CBCP1 iso3 (human) SFPLEPLSRERAHKL S241
CBCP1 (mouse) sFPLEPLsRERAHKL S295-p
CBCP1 (rat) SFPLEPLSRERAHKL S295
K301-ub
LsRERAHkLEAISRL
0 1
CBCP1 (human) LsRERAHkLEAISRL K301-ub
CBCP1 iso3 (human) LSRERAHKLEAISRL K247
CBCP1 (mouse) LsRERAHKLEAISRL K301
CBCP1 (rat) LSRERAHKLEAISRL K301
S324-p
RRSARKRsAsADNLt
Upstream
0 46
Treatment
  • vemurafenib
CBCP1 (human) RRSARKRsAsADNLt S324-p
CBCP1 iso3 (human) RRSARKRSASADNLT S270
CBCP1 (mouse) RKPMRKRsAsADNLI S324-p
CBCP1 (rat) RKPMRKRsAsADNLI S324-p
S326-p
SARKRsAsADNLtLP
Upstream
Downstream
2 144
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • autophagy, induced
Kinase, in vitro:
  • AMPKA1 (human)
Putative in vivo kinases:
  • AMPKA1 (human)
Treatment
  • A-769662
  • acadesine
  • compound_C
  • EBSS
  • glucose_starvation
  • ionomycin
  • nocodazole
  • siRNA
CBCP1 (human) SARKRsAsADNLtLP S326-p
CBCP1 iso3 (human) SARKRSASADNLTLP S272
CBCP1 (mouse) PMRKRsAsADNLILP S326-p
CBCP1 (rat) PMRKRsAsADNLILP S326-p
T331-p
sAsADNLtLPRWsPA
0 14
CBCP1 (human) sAsADNLtLPRWsPA T331-p
CBCP1 iso3 (human) SASADNLTLPRWSPA T277
CBCP1 (mouse) sAsADNLILPRWSPA I331
CBCP1 (rat) sAsADNLILPRWSPA I331
S336-p
NLtLPRWsPAIIS__
Upstream
1 2
Putative in vivo kinases:
  • CDK16 (human)
CBCP1 (human) NLtLPRWsPAIIS__ S336-p
CBCP1 iso3 (human) NLTLPRWSPAIIS__ S282
CBCP1 (mouse) NLILPRWSPAIIS__ S336
CBCP1 (rat) NLILPRWSPAIIS__ S336